Skip to main content
. 2020 Sep 8;8(2):e001064. doi: 10.1136/jitc-2020-001064

Table 5.

Immune-related adverse events (any grade in any patient; n=156)

Patients, n (%)
Any grade Grade ≥3
Any immune-related adverse event 31 (19.9) 1 (0.6)
Immune-mediated thyroid disorder 15 (9.6) 0
 Hypothyroidism 14 (9.0) 0
 Hyperthyroidism 1 (0.6) 0
Immune-mediated rash or pruritus 12 (7.7) 0
 Pruritus 6 (3.8) 0
 Rash 6 (3.8) 0
 Rash maculopapular 2 (1.3) 0
 Pruritus generalized 1 (0.6) 0
 Rash erythematous 1 (0.6) 0
 Rash macular 1 (0.6) 0
Immune-mediated pneumonitis 5 (3.2) 1 (0.6)
Immune-mediated colitis 3 (1.9) 0
 Diarrhea 2 (1.3) 0
 Colitis 1 (0.6) 0
Immune-mediated adrenal insufficiency 1 (0.6) 0
Autoimmune disorder 1 (0.6) 0